MATRIPHARM INT INC has a total of 12 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and macromolecular chemistry and polymers are CHENGDU OLYMVAX BIOPHARMACEUTICAL CO LTD, HEILONGJIANG ZHONGSHENG BIOLOGICAL ENG CO LTD and GREENMARK BIOMEDICAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | South Africa | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Le Tien Canh | 12 |
#2 | Mateescu Mircea-Alexandru | 2 |
Publication | Filing date | Title |
---|---|---|
US2020108017A1 | Two speed monolithic system for controlled release of drugs | |
US2020054565A1 | Monolithic tablets based on carboxyl polymeric complexes for controlled drug release | |
CA3015400A1 | Dual-rate release formulation with high drug loading | |
WO2017143439A1 | Monolithic composition for dual-rate release with high drug loading |